Objective To comprehensively analyze the research trends in the reported outcomes for lung cancer patients and related management, reveal research hotspots and trends, and provide references for future related research. Method We searched for relevant literature in the Web of Science core databases, PubMed, and Scopus databases from inception to December 31, 2023. CiteSpace bibliometric software was used to analyze the distribution of authors, countries and regions, research institution, keyword co-occurrence, keyword emergence, and draw keyword clusters and timeline analysis maps. Result A total of 479 qualified literatures were included, and the number of published papers showed an overall upward trend. The highest number of articles are issued in the United States. The journal with the highest number of articles is Journal of Pain and Symptom Management, and the journal with the highest citation frequency is Journal of Clinical Oncology. The results of keyword outburst analysis showed that hot topics were mainly focused on "prospective study", "physical activity", "exercise", "vomiting", "survival". ConclusionAlthough the research on lung cancer surgical treatment and the management of patients is developing rapidly, the application of management based on reported outcomes of lung cancer patients in lung cancer surgery is still in the exploratory stage and needs to be continuously improved in clinical research and clinical practice. The establishment of relevant assessment systems needs to be improved. In the future, more researchers need to focus on this area, strengthen multi-regional and multi-institutional collaborations, and accelerate research progress in the management of reported outcomes in lung cancer patients.
In 2025, the American Cancer Society published "Cancer Statistics, 2025", which projected cancer data for the upcoming year based on incidence data collected by central cancer registries (through 2021) and mortality data obtained from the National Center for Health Statistics (through 2022). Similarly, the National Cancer Center of China released "Cancer Incidence and Mortality in China, 2022" in December 2024, analyzing data from over 700 cancer registries across the country. This study provides a comparative analysis of cancer incidence and mortality trends in China and the United States during the same period, with a focus on sex- and age-specific distributions and long-term changes in cancer patterns. Long-term trends indicate that lung and liver cancer mortality rates in China have declined, primarily due to tobacco control measures and hepatitis B vaccination programs. However, the burden of gastric and esophageal cancers remains substantial. In the United States, mortality rates for colorectal and lung cancers have continued to decline, largely attributed to widespread screening programs and advances in immunotherapy. As economic growth and social development, China’s cancer profile is gradually shifting towards patterns observed in countries with high human development index. However, the prevention and control of upper gastrointestinal cancers remains a critical public health challenge that requires further attention.